2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now

There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well. Since they belong to a defensive industry, drugmakers tend to perform better than most companies even in the worst economic downturns. Additionally, long-term trends, such as the world's aging population, will drive a rising demand for pharmaceutical products over the coming decades, positioning the industry for long-term growth.Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry that look like strong buys right now: Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY). Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool